3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
17
Neoplasms
9
Head and Neck Neoplasms
8
Prostatic Neoplasms
7
Ovarian Neoplasms
6
Lung Neoplasms
5
Pancreatic Neoplasms
4
Endometrial Neoplasms
4
Urinary Bladder Neoplasms
3
Rectal Neoplasms
3
Oropharyngeal Neoplasms
3
Motor Activity
3
Kidney Neoplasms
3
Health Behavior
3
Depression
3
Carcinoma, Squamous Cell
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Smoking Cessation
2
Multiple Myeloma
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Communication
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Carcinoma, Renal Cell
2
Anxiety Disorders
2
Alopecia
2
Xerostomia
1
Interventions
fludarabine
5
fludarabine phosphate
4
Cyclophosphamide
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
Surveys and Questionnaires
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Immune System Diseases
×
Surveys and Questionnaires
×
Clear all
NCT04656873
2025-09-04
IOG
UNC Lineberger Comprehensive Cancer Center
Active not recruiting
32 enrolled